Working Smarter: Using Control Charts to Tackle the High Cost of Clinical Variation
Consistent, accurate, and timely clinical reporting has the power to prompt care teams to adhere to clinical protocols and be mindful of how they stack up against peers and national benchmarks.
Helping Emergency Department Clinicians Understand the Costs of Care
Finance leaders should collaborate with clinical leaders on clinician cost education so they have a greater awareness of room fees, nursing fees, and radiology fees needed to treat ED patients.
Hospital COPD Bundle Curbs Costly Readmissions
University of Cincinnati Medical Center used improvement science to develop and implement a ‘COPD care bundle’ for COPD patients who are often readmitted due to care-delivery failures.
Healthcare Executives Dissatisfied with Cost Transformation Progress
A Kaufman Hall survey found that 75 percent of healthcare executive respondents rate their cost transformation success as average to below average.
Inflammatory Disease and Diabetes Treatment Top the List of Drug Spending Increases Through 2019
Increased utilization will drive a 10-13 percent increase in drug spending through 2019. The biggest increases will occur in drug spending for inflammatory diseases and diabetic treatment.
Healthcare Cost Containment: October 2017
Subscribers can access the October 2017 issue of Healthcare Cost Containment.
New Survey Finds Current Cost Transformation Initiatives Lack Required Urgency
Healthcare executives responding to a recent survey overwhelming agree that transforming costs is a “significant” or “very significant” need, but more than 50 percent have no cost reduction targets for the next five years or have a goal of 1-5 percent—a range that is far below what will be required to transform cost structures.
How Price Transparency Can Lower Healthcare Costs
Joseph Sanginiti explains how healthcare providers, health plans, and consumers must work together to manage the cost of health care.
$28M in Healthcare Costs Associated with Opioid Epidemic
Health care accounts for about one-third of the total $78.5 billion costs attributable to the prescription opioid epidemic.
Finding Cost Savings in the Era of Value
The transition to value requires healthcare organizations to control costs while maintaining quality and patient satisfaction.